Table 1 Clinical and EMSa characteristics
Characteristics | Total (n = 134) | Neurological outcome at hospital discharge | p-value | |
|---|---|---|---|---|
Good-CPCb group (n = 15) | Poor-CPCb group (n = 119) | |||
Age, median (IQRc) | 60 (48–71) | 51 (36–65) | 61 (49–84) | 0.009 |
Male, n (%) | 114 (85.1) | 14 (93.3) | 100 (84.0) | 0.343 |
Hypertension, n (%) | 33 (24.6) | 5 (33.3) | 28 (23.5) | 0.524 |
Diabetes, n (%) | 24 (17.9) | 1 (6.7) | 23 (19.3) | 0.306 |
Cerebrovascular disease, n (%) | 3 (2.2) | 0 (0) | 3 (2.2) | 1.000 |
Heart disease, n (%) | 26 (19.4) | 2 (13.3) | 24 (20.2) | 0.735 |
Arrest location - Public space, n (%) | 56 (41.8) | 9 (60.0) | 47 (39.5) | 0.131 |
Witnessed arrest, n (%) | 91 (67.9) | 11 (73.3) | 80 (67.2) | 0.774 |
Bystander CPRd, n (%) | 105 (78.4) | 14 (93.3) | 91 (76.5) | 0.137 |
Response time (minutes) | 7 (6–9) | 7 (6–11) | 7 (6–15) | 0.441 |
Defibrillation time (minutes) | 11 (9–13) | 10 (9–17) | 11 (9–20) | 0.205 |
Number of shocks | 7 (5–9) | 6 (4–7) | 7 (5–9) | 0.421 |
TTMe, n(%) | 15 (11.2) | 6 (40.0) | 9 (7.6) | 0.002 |
Call-to-amiodarone administration interval (minutes) | 23 (19–26.3) | 19 (18–22) | 23 (19–28) | 0.009 |
Call-to-epinephrine administration interval (minutes) | 18 (15–22) | 17 (15–19) | 18 (15–22) | 0.113 |